Koninklijke Philips (PHG) Long-Term Investments (2009 - 2026)
Koninklijke Philips' (PHG) quarterly Long-Term Investments came in at $166.2 million in Q1 2026, down 36.01% year-on-year from $259.8 million in Q1 2025, and down 3.5% quarter-over-quarter from $172.3 million in Q4 2025.
Koninklijke Philips (PHG) Long-Term Investments (2009 - 2026) Analysis & Trends
Koninklijke Philips' Long-Term Investments history runs 18 years deep, the most recent figure standing at $166.2 million for Q1 2026.
- On a quarterly basis, Long-Term Investments fell 36.01% year-over-year to $166.2 million in Q1 2026; TTM through Mar 2026 was $166.2 million, a 36.01% decrease from a year earlier, with the FY2025 full-year figure at $172.3 million, down 37.27% from the prior year.
- Long-Term Investments fell to $166.2 million in Q1 2026 per PHG's latest filing, from $172.3 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $680.8 million in Q2 2022 and bottomed at -$93.3 million in Q3 2024.
- The 5-year median for Long-Term Investments is $259.8 million (2025), against an average of $278.4 million.
- Across the five-year window, Long-Term Investments plunged 38.67% in 2024 and soared 713.23% in 2025, its largest moves.
- Year by year, Long-Term Investments stood at $547.9 million in 2022, then dropped by 25.18% to $409.9 million in 2023, then slumped by 33.01% to $274.6 million in 2024, then plunged by 37.27% to $172.3 million in 2025, then slipped by 3.5% to $166.2 million in 2026.
- Per Business Quant, the three latest PHG Long-Term Investments figures stand at $166.2 million (Q1 2026), $172.3 million (Q4 2025), and $170.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 166.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 121.00 Mn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 166.25 Mn |
| Dec 31, 2025 | 172.28 Mn |
| Sep 30, 2025 | 170.68 Mn |
| Jun 30, 2025 | 253.56 Mn |
| Mar 31, 2025 | 259.82 Mn |
| Dec 31, 2024 | 274.63 Mn |
| Sep 30, 2024 | -93.35 Mn |
| Jun 30, 2024 | 311.22 Mn |
| Mar 31, 2024 | -42.37 Mn |
| Dec 31, 2023 | 409.93 Mn |
| Jun 30, 2023 | 507.44 Mn |
| Dec 31, 2022 | 547.87 Mn |
| Jun 30, 2022 | 680.78 Mn |
| Dec 31, 2021 | 323.74 Mn |
| Jun 30, 2021 | 445.58 Mn |
| Dec 31, 2020 | 174.07 Mn |
| Jun 30, 2020 | 247.83 Mn |
| Dec 31, 2019 | 79.70 Mn |
| Jun 30, 2019 | 282.03 Mn |
| Dec 31, 2018 | 226.00 Mn |